In order to define new genetic pathways of colorectal carcinogenesis, we sought evidence for the primary drivers of the associations between somatic mutations (KRAS, NRAS, BRAF, PIK3CA, TP53, FBXW7), CIN, MSI and the three sites of LOH (see Supplementary material, Tables S2, S3). This evidence concerns the gene TP53 and medical procedure.